Navigation Links
DURECT Corporation Announces Second Quarter 2009 Financial
Date:8/3/2009

Complete Response Letter from the FDA in December 2008 indicating that the NDA is not approved in its present form. King Pharmaceuticals, the commercialization partner of Pain Therapeutics for Remoxy, assumed responsibility for further development of Remoxy from Pain Therapeutics in March 2009 and met with the Food and Drug Administration (FDA) on July 2, 2009 to discuss the Complete Response Letter. According to King Pharmaceuticals and Pain Therapeutics, the outcome of that meeting provided King with a clear path forward to resubmit the REMOXY NDA and to address all FDA comments in the Complete Response Letter. According to the King Pharmaceuticals / Pain Therapeutics press release, King now anticipates the resubmission of the NDA could occur mid-year 2010. King has stated that it remains committed to the development and commercialization of REMOXY and looks forward to working closely with the FDA toward approval of the product. REMOXY, an investigational drug, is a long acting oral formulation of oxycodone intended to treat moderate to severe pain. Based on DURECT's ORADUR(R) technology, which is covered by issued patents and pending patent applications owned by us, REMOXY is designed to resist common methods of prescription drug misuse and abuse. -- POSIDUR(TM) (SABER(TM)-Bupivacaine). During the quarter, DURECT continued enrollment in our approximately 60 patient Phase IIb clinical study in shoulder surgery. In addition, Nycomed continued enrollment in a Phase IIb study in hysterectomy patients and a Phase IIb study in shoulder surgery patients. We are in active discussions with multiple potential partners regarding licensing of the U.S./Canada and Asian rights to this program. POSIDUR is our investigational post-operative pain r
'/>"/>
SOURCE DURECT Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. DURECT to Present at the BMO Capital Markets Healthcare Conference
2. DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call
3. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
4. DURECT Corporation Invites You to Join its First Quarter 2009 Earnings Conference Call
5. DURECT to Participate in Cowen and Company Healthcare Conference
6. Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
7. DURECT Corporation Invites You to Join Its Fourth Quarter 2008 Earnings Conference Call
8. DURECT Corporation to Participate in Upcoming Healthcare Conferences
9. DURECT Corporation to Participate in Upcoming Healthcare Conferences
10. DURECT Corporation Invites You to Join Its Third Quarter 2008 Earnings Conference Call
11. DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... (PRWEB) August 21, 2014 Transvaginal ... Bard, Inc. continue to move forward in the ... Southern District of West Virginia, Bernstein Liebhard LLP ... August 14th, the Court has established new stipulated ... special handling, division, storage and preservation. (In re ...
(Date:8/21/2014)... care physicians in rural communities do not routinely ... to Penn State medical and public health researchers. ... have limited resources if they seek help., "Rural ... women," said Jennifer S. McCall-Hosenfeld, a primary care ... health sciences, Penn State College of Medicine. "However, ...
(Date:8/21/2014)... London, UK (PRWEB) August 21, 2014 ... from USD 15.6 billion in 2014 and reach USD ... during the forecast period. The drivers of such growth ... products, rising obese and diabetic population, and surging ageing ... costs of state-of-the-art wound care products. Region-wise, North America ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Lauren Collura, a ... the 2014 “Back to the Boardwalk” Facebook sweepstakes. Lauren, her ... a beautiful four-bedroom beachfront house in Lavallette beginning this Saturday. ... to the Boardwalk” sweepstakes. Last year, Horizon Blue Cross Blue ... communities after Superstorm Sandy and decided to make it a ...
(Date:8/21/2014)... THURSDAY, Aug. 21, 2014 (HealthDay News) -- In a ... that pregnant women avoid eating tuna due to concerns ... tuna, which is second only to shrimp as the ... encourage pregnant women to avoid all tuna," Jean Halloran, ... advocacy division of Consumer Reports, said in a news ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 3Health News:Primary care physicians can be critical resource for abused women in rural areas 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 3Health News:Consumer Reports Advises Pregnant Women to Avoid Tuna 2
... Nov. 5 Attorneys from Dallas, Rasansky Law Firm ... court on behalf of the mother of a 2-year-old girl who ... year ago. The lawsuit includes claims that the day care,s owners ... the child,s death from showing up on a state licensing database. ...
... is pleased to announce their standing in the latest ... quick, confidential performance ratings and comparisons of technology vendors, ... overall in their Q3 2009 Customer Satisfaction Industry Report. ... customer satisfaction score was the lowest ever reported by ...
... FRANCISCO, Nov. 5 Quantros, Inc., an industry leader ... point of care data surveillance solutions, today announced the ... ), a publicly traded company spun off from Cardinal ... were not disclosed. , This latest addition to ...
... Investments to ... ... nonprofit venture capital firm that invests in entrepreneurs who are building businesses to serve the ... Hill Eye and Laser Centre (UHEAL) in Kenya, both of which provide advanced eye care ...
... study finds, , THURSDAY, Nov. 5 (HealthDay News) -- What ... a good night,s sleep come more easily. , A study ... the odds of having disturbed sleep in the seven years ... years before they stopped working. , Sleep improvements probably had ...
... , WATSONVILLE, Calif., Nov. 5 Nordic Naturals ... especially for pregnant women to ensure adequate DHA, an ... for the new mother and developing baby. Prenatal DHA ... the leading non-profit organization in the United States that ...
Cached Medicine News:Health News:The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit; State Investigation Finds Evidence of Negligence at Woodbridge Day School 2Health News:ChemSW Rated Top Vendor Overall for Customer Satisfaction in Q3 2009 by VendorRate 2Health News:Quantros Acquires MediQual(TM) From CareFusion Corporation 2Health News:Quantros Acquires MediQual(TM) From CareFusion Corporation 3Health News:Acumen Fund Announces Two Investments Providing Advanced Eye Care Services in India and Kenya 2Health News:Acumen Fund Announces Two Investments Providing Advanced Eye Care Services in India and Kenya 3Health News:Acumen Fund Announces Two Investments Providing Advanced Eye Care Services in India and Kenya 4Health News:Without Job Stress, Retirees Sleep Better 2Health News:Nordic Naturals Professional Exclusive Division Introduces Prenatal DHA An Omega-3 Fatty Acid Supplement for Pregnant Women 2
(Date:8/21/2014)... , Aug. 21, 2014 Professional ... in paediatric medicine by awarding the three best ... Formulation initiative (EuPFI) conference . The Formulating ... – 18 in Athens, Greece ... pharmacy students and professionals, from which three winners ...
(Date:8/21/2014)... , Aug. 21, 2014   Royal ... PHIA) today announced it has received 510(k) clearance ... market its precision planning application for Transcatheter Aortic-Valve ... TAVI application provides interventionalists with pre-procedural, high-precision positioning ... Philips TAVI planning application is available as part ...
(Date:8/21/2014)... JOSE, Calif. , Aug. 21, 2014  SI-BONE, ... medical device company that pioneered the use of the ... (MIS) device indicated for fusion of the sacroiliac (SI) ... ) published an update to its Lumbar Fusion Medical ... SI joint fusion procedure.  The policy states that the ...
Breaking Medicine Technology:Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3
... KVM Switches to be First Units to Sport New ... ... ATEN Technology, Inc., an,innovator of high-quality KVM (keyboard/video/mouse) and remote,connectivity ... the first LCD KVM switches to feature,product-protected antimicrobial nanocoating. The ...
... LA JOLLA, Calif., Sept. 10 TorreyPines,Therapeutics, Inc. ... its third,Phase I clinical trial for NGX267, in ... with schizophrenia (CIAS). The,compound, a functionally selective muscarinic ... when given orally to healthy male volunteers,once-daily for ...
Cached Medicine Technology:Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces 2Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces 3Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces 4TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia 2TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia 3
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 100-1,000 microliter range....
... Pipettor is the #1 Pipettor for ... comfort, and reliability. Continuously adjustable. Features ... sub-micrometer. Easy interchangeable ejector buttons to ... Adjustable rapid pipet tip ejector with ...
... adjustable, air-displacement pipette with a patented multifunctional ... of the Pipetman family, sharing many of ... We also added a number of features ... models cover the full range of volumes ...
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
Medicine Products: